Literature DB >> 18094334

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.

B Banwell1, S Tenembaum, V A Lennon, E Ursell, J Kennedy, A Bar-Or, B G Weinshenker, C F Lucchinetti, S J Pittock.   

Abstract

OBJECTIVE: To determine seroprevalence of neuromyelitis optica (NMO)-IgG in childhood CNS inflammatory demyelinating disorders.
METHODS: We analyzed demographic, clinical, and radiologic data in a blinded fashion and assessed serum NMO-IgG status for 87 children: 41 with relapsing-remitting multiple sclerosis (RRMS), 17 with NMO, 13 with monophasic/recurrent optic neuritis (ON), 13 with transverse myelitis, of whom 10 were longitudinally extensive on MRI spine (LETM), and another 3 with LETM in the context of acute disseminated encephalomyelitis (ADEM).
RESULTS: Ten of the 87 children (11%) were seropositive. Eight of 17 with NMO (47%) were seropositive (7 of 9 with relapsing NMO [78%], 1 of 8 with monophasic NMO [12.5%]). Two other children were seropositive: 1 of 5 with recurrent ON and one child with recurrent LETM. No seropositive case was identified among 41 with RRMS (14% of whom had LETM at some point in their clinical course), 8 with monophasic ON, 9 with monophasic LETM, or 3 with LETM in the context of ADEM.
CONCLUSIONS: The similar frequency of neuromyelitis optica (NMO)-IgG in both childhood and adult cases of NMO, and its rarity in relapsing-remitting multiple sclerosis, supports the concept that these diseases have a similar pathogenesis in childhood and adulthood. It is noteworthy that none of nine children with monophasic longitudinally extensive transverse myelitis (LETM) was NMO-IgG-seropositive. Furthermore, LETM does not appear to be as predictive of an NMO spectrum disorder in children as it is in adults. Longitudinal studies of larger pediatric LETM cohorts are required to ascertain whether the absence of NMO-IgG is a negative predictor for relapse in this childhood entity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094334     DOI: 10.1212/01.wnl.0000284600.80782.d5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  59 in total

1.  Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists.

Authors:  Amy T Waldman; Mark P Gorman; Mary R Rensel; Tracy E Austin; Deborah P Hertz; Nancy L Kuntz
Journal:  J Child Neurol       Date:  2011-04-25       Impact factor: 1.987

2.  Effects of age and sex on aquaporin-4 autoimmunity.

Authors:  Amy M L Quek; Andrew McKeon; Vanda A Lennon; Jayawant N Mandrekar; Raffaele Iorio; Yujuan Jiao; Chiara Costanzi; Brian G Weinshenker; Dean M Wingerchuk; Claudia F Lucchinetti; Elizabeth A Shuster; Sean J Pittock
Journal:  Arch Neurol       Date:  2012-08

3.  Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.

Authors:  Setty M Magaña; Sean J Pittock; Vanda A Lennon; B Mark Keegan; Brian G Weinshenker; Claudia F Lucchinetti
Journal:  Arch Neurol       Date:  2009-08

4.  Neuromyelitis optica - an update: 2007-2009.

Authors:  Anu Jacob
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

5.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

6.  Longitudinally Extensive Transverse Myelitis.

Authors:  Deepti Chawla; Devendra Mishra; Sapna Singh; Monica Juneja
Journal:  Indian J Pediatr       Date:  2018-06-04       Impact factor: 1.967

Review 7.  Longitudinally extensive myelopathy in children.

Authors:  Danielle Eckart Sorte; Andrea Poretti; Scott D Newsome; Eugen Boltshauser; Thierry A G M Huisman; Izlem Izbudak
Journal:  Pediatr Radiol       Date:  2015-01-31

Review 8.  Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Authors:  Marios C Papadopoulos; Jeffrey L Bennett; Alan S Verkman
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

9.  Anti-MOG Antibody Seropositive Neuromyelitis Optica: A Rare Pediatric Case.

Authors:  Gonca Koç; Nurettin Bayram; Ahmet Sami Güven; Doğan Bahadır İnan; Ali Kaya
Journal:  Noro Psikiyatr Ars       Date:  2019-02-05       Impact factor: 1.339

10.  Diagnostic criteria for pediatric multiple sclerosis.

Authors:  Jennifer P Rubin; Nancy L Kuntz
Journal:  Curr Neurol Neurosci Rep       Date:  2013-06       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.